Delivery of cisplatin from pluronic co-polymer systems: Liposome inclusion and alginate coupling

Journal of Biomaterials Science, Polymer Edition

Volumn 20, Issue 7-8, 2009, Pages 1031-1047

  Fang, Jia You ^a   Hsu, Shu Hui ^b   Leu, Yann Lii ^a   Hu, Jiuan Wen ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

Author keywords

Alginate; Cisplatin; Liposomes; Melanoma; Pluronic F127

Indexed keywords

ALGINATE; DERMATOLOGY; HYDROGELS; LIPOSOMES; MAMMALS; ONCOLOGY; PHYSICOCHEMICAL PROPERTIES; SCANNING ELECTRON MICROSCOPY; SOL-GEL PROCESS; SOL-GELS; TARGETED DRUG DELIVERY;

BURST RELEASE; CIS-PLATIN; CO-POLYMER SYSTEMS; DRUG RELEASE; MELANOMA; PLURONIC F-127; SEM IMAGE; SOL-GEL TRANSITIONS;

CONTROLLED DRUG DELIVERY;

ALGINIC ACID; CISPLATIN; LIPOSOME; POLOXAMER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG FORMULATION; DRUG RELEASE; FEMALE; HYDROGEL; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; TRANSITION TEMPERATURE; VISCOMETRY;

MUS;

EID: 67649122351     PISSN: 09205063     EISSN: 15685624     Source Type: Journal    
DOI: 10.1163/156856209X444493     Document Type: Article

References (40)

1. C. Xiao, X. Qi, Y. Maitani and T. Nagai, J. Pharm. Sci. 93, 1718 (2004).
2. K. Avgoustakis, A. Beletsi, Z. Panagi, P. Klepetsanis, A. G. Karydas and D. S. Ithakissios, J. Control. Rel. 79, 123 (2002).
3. M. Konishi, Y. Tabata, M. Kariya, A. Suzuki, M. Mandai, K. Nanbu, K. Takakura and S. Fujii, J. Control. Rel. 92, 301 (2003).
4. N. Kashyap, N. Kumar and M. N. V. Ravi Kumar, Crit. Rev. Ther. Drug Carrier Syst. 22, 107 (2005).
5. J. J. Escobar-Chávez, M. López-Cervantes, A. Naïk, Y. N. Kalia, D. Quintanar-Guerrero and A. Ganem-Quintanar, J. Pharm. Pharm. Sci. 9, 339 (2006).
6. T. Moore, S. Croy, S. Mallapragada and N. Pandit, J. Control. Rel. 67, 191 (2000).
7. E. Ruel-Gariépy, G. Leclair, P. Hildgen, A. Gupta and J. C. Leroux, J. Control. Rel. 82, 373 (2002).
8. X. Y. Xiong, K. C. Tam and L. H. Gan, J. Nanosci. Nanotechnol. 6, 2638 (2006).
9. L. Bromberg, J. Phys. Chem. B 102, 1956 (1998).
10. G. Grassi, A. Crevatin, R. Farra, G. Guarnieri, A. Pascotto, B. Rehimers, R. Lapasin and M. Grassi, J. Colloid Interface Sci. 301, 282 (2006).
11. O. Séchoy, G. Tissié, C. Sébastian, F. Maaurin, J.-Y. Driot and C. C. Trinquand, Int. J. Pharm. 207, 109 (2000).
12. K. Y. Cho, T. W. Chung, B. C. Kim, M. K. Kim, J. H. Lee, W. R. Wee and C. S. Cho, Int. J. Pharm. 260, 83 (2003).
13. N. Bhattari, H. R. Ramay, J. Gunn, F. A. Matsen and M. Zhang, J. Control. Rel. 103, 609 (2005).
14. M. S. Newman, G. T. Colbern, P. K. Working, C. Engbers and M. A. Amantea, Cancer Chemother. Pharmacol. 43, 1 (1999).
15. T. L. Hwang, W. R. Lee, S. C. Hua and J. Y. Fang, J. Dermatol. Sci. 46, 11 (2007).
16. J. Y. Fang, C. F. Hung, T. L. Hwang and Y. L. Huang, J. Drug Target. 13, 19 (2005).
17. J. Y. Fang, W. R. Lee, S. C. Shen and Y. L. Huang, J. Dermatol. Sci. 42, 101 (2006).
18. J. P. Chen and T. H. Cheng, Macromol. Biosci. 6, 1026 (2006).
19. M. P. Stevens (Ed.), in: Polymer Chemistry, Chapter 2, p. 4. Oxford University Press, New York, NY (1990).
20. K. Jores, A. Haberland, S. Wartewig, K. Mäder and W. Mehnert, Pharm. Res. 22, 1887 (2005).
21. T. Yotsuyanagi, M. Usami, Y. Noda and M. Nagata, Int. J. Pharm. 246, 95 (2002).
22. M. Guzmán, F. F. García, J. Molpeceres and M. R. Aberturas, Int. J. Pharm. 80, 119 (1992).
23. A. Cabana, A. Ait-Kadi and J. Juhasz, J. Colloid Interface Sci. 190, 307 (1997).
24. E. Ruel-Gariépy and J.-C. Leroux, Eur. J. Pharm. Biopharm. 58, 409 (2004).
25. J. Li, X. Ni and K. W. Leong, J. Biomed. Mater. Res. A 65, 196 (2003).
26. N. K. Pandit and J. Kisaka, Int. J. Pharm. 145, 129 (1996).
27. V. DiTizio, C. Karlgard, L. Lilge, A. E. Khoury, M. W. Mittelman and F. DiCosmo, J. Biomed. Mater. Res. 51, 96 (2000).
28. T. Chandy, J. Biomater. Appl. 16, 275 (2002).
29. S. Cafaggi, E. Russo, R. Stefani, R. Leardi, G. Caviglioli, B. Parodi, G. Bignardi, D. De Totero, C. Aiello and M. Viale, J. Control. Rel. 121, 110 (2007).
30. R. Narayani and K. P. Rao, Int. J. Pharm. 138, 121 (1996).
31. J. S. Zhang, T. Imai, A. Suenaga and M. Odagiri, Int. J. Pharm. 240, 23 (2002).
32. M. Konishi, Y. Tabata, M. Kariya, H. Hosseinkhani, A. Suzuki, K. Fukuhara, M. Mandai, K. Takakura and S. Fujii, J. Control. Rel. 103, 7 (2005).
33. M. R. Kim and T. G. Park, J. Control. Rel. 80, 69 (2002).
34. A. Bochot, E. Fattal, A. Gulik, G. Couarraze and P. Couvreur, Pharm. Res. 15, 1364 (1998).
35. K. Maruyama, O. Ishida, T. Takizawa and K. Moribe, Adv. Drug Deliv. Rev. 40, 89 (1999).
36. G. M. Zentner, R. Rathi, C. Shih, J. C. McRea, M. H. Seo, H. Oh, B. G. Rhee, J. J. Mestecky, Z. Moldoveanu, M. Morgan and S. Weitman, J. Control. Rel. 72, 203 (2001).
37. M. M. Amiji, P. K. Lai, D. B. Shenoy and M. Rao, Pharm. Dev. Technol. 7, 195 (2002).
38. K. Arashiro, Plast. Reconstr. Surg. 110, 717 (2002).
39. J. H. Kim, Y. S. Kim, K. Park, S. Lee, H. Y. Nam, K. H. Min, H. G. Jo, J. H. Park, K. Choi, S. Y. Jeong, R. W. Park, I. S. Kim, K. Kim and I. C. Kwon, J. Control. Rel. 127, 41 (2008).
40. A. D. Carvalho Júnior, F. P. Vieira, V. J. De Melo, M. T. P. Lopes, J. N. Silveira, G. A. Ramaldes, A. Garnier-Suillerot, E. C. Pereira-Maia and M. C. De Oliveira, Braz. J. Med. Biol. Res. 40, 1149 (2007).